Table 1.
Subject baseline characteristics.
| All subjects | Standard TIV | LTIV (1/3rd) + Adj | p Value⁎ | LTIV (1/10th) + Adj | |
|---|---|---|---|---|---|
| Number of subjects | N = 109 | N = 48 | N = 50 | N = 11 | |
| Age, median (IQR) | 45(26, 55) | 44(26, 52) | 44.5(23, 55) | n.s. | 51(42, 55) |
| Gender | |||||
| Males, n (%) | 52(48) | 22(45.8) | 23(46) | n.s. | 7(64) |
| Females, n (%) | 57(52) | 26(54.2) | 27(54) | (36) | |
| Race, n (%) | |||||
| Caucasian | 101(92.8) | 46(95.8) | 45(90) | n.s. | 10(90) |
| Asian | 8(7.2) | 2(4.2) | 5(10) | 1(10) | |
| Mean baseline HI titer | |||||
| A/NC/20/99a | 23.4 | 23.6 | 23.8 | n.s. | 22.1 |
| A/SI/3/2006 | 11.4 | 10.8 | 12.1 | n.s. | 11.1 |
| A/W/67/2005a | 16.8 | 20.7 | 15.7 | n.s. | 11.3 |
| A/U/716/2007 | 8.9 | 10.1 | 9.0 | n.s. | 6.4 |
| B/M/2506/2004a | 20.2 | 23.8 | 16.5 | n.s. | 22.6 |
| B/F/4/2006 | 37.3 | 44.4 | 36.6 | n.s. | 24.5 |
a
Vaccine strains.
⁎
Stated p values are for the comparison of baseline characteristics of standard TIV and LTIV(1/3rd) + Adj groups. IQR = interquartile range, n.s = not significant.